Specifications of EMCDDA databases

Die Anfrage war erfolgreich.

Dear European Monitoring Centre for Drugs and Drug Addiction,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting:

- The specifications for all databases created or maintained by EMCDDA. If specifications are not available for any database, please instead provide whatever documentation you hold describing the purpose, nature, or information contained in that database.
- Any documentation of EMCDDA procedures for database management. For example data protection guidelines, security review procedures, backup requirements.

Yours faithfully,

Dan O'Huiginn

Gonçalo Felgueiras e Sousa, Europäische Beobachtungsstelle für Drogen und Drogensucht

Dear Mr O'Huiginn,

Thank you for your email of 19 April, which has received our fullest
attention.

Your request is being handled and you can normally expect a final reply
within one month of receiving this email.

Yours sincerely,

Gonçalo Felgueiras

Zitate anzeigen

Enquiries, Europäische Beobachtungsstelle für Drogen und Drogensucht

Dear Mr O’Huiginn,

Please find below the EMCDDA reply to your request, received on 19 April
2013, to be provided with ‘specifications for all databases created or
maintained by the EMCDDA’ as well as ‘any documentation of the EMCDDA
procedures for database management’ - under Article 15 of the TFEU and,
where applicable, Regulation 1049/2001:
 
a) Existing EMCCDA databases/web-based tools and its specifications:
The following databases have been created and are currently
maintained/managed by the EMCDDA:
1-     Best practice portal, including the three following subchapters:
Standards and guidelines; Exchange on Drug Demand Reduction Action
(EDDRA); and The Evaluation Instruments Bank (EIB).
[1]<http://www.emcdda.europa.eu/best-practice>;
2-     Country overviews: Country overviews provide a structured synopsis
of the trends and characteristics of national drug problems. They consist
of a summary of the national drug situation, key statistics at a glance
and a barometer showing the drug use prevalence position of each country.
< [2]http://www.emcdda.europa.eu/countries>;
3-     Drug profiles: sound descriptions of drugs in the form of ‘drug
profiles’. Presented in a standardised way, each profile briefly gives the
chemistry, pharmacology, synthesis and precursors of each substance, as
well as analysis, physical form (e.g. powder, tablet) and mode of use
(e.g. ingested, snorted, injected)
[3]<http://www.emcdda.europa.eu/drug-profiles>;
4-     The European Legal Database on Drugs (ELDD): it is the EMCDDA's
online database of information on European drugs-related legislation for
the Member States and Norway. Information for the candidate countries is
being added as it becomes available. [4]<http://www.emcdda.europa.eu/eldd>
5-     Statistical bulletin: the Statistical bulletin is published yearly
by the EMCDDA and consists of over 400 tables and 100 graphs of the most
recent available data on the drug situation in Europe, all available to
view interactively on screen and download in Excel
[5]<http://www.emcdda.europa.eu/stats12>
6-     Fonte: a database to annually collect and store data-sets
concerning different aspects of the drug phenomenon, as provided by the
Reitox national focal points, our partners in the Member States. The data
is the basis for a great part of our analysis.
[6]<http://www.emcdda.europa.eu/html.cfm/ind...>.
 
As regards the specifications for each of the databases, any available
information, namely regarding the purpose, nature or information contained
in that database, can be found through each of the links provided above.
Any further information concerning each one of the resources described can
be found on our public web site at <[7]www.emcdda.europa.eu>.
 
b) EMCDDA procedures for database management’
On the concrete issue of the database management and data protection, the
following procedures apply, as indicated at the respective privacy
statement for the EMCDDA information and communication technologies (ICT)
infrastructure:
·       All EMCDDA ICT services and systems are provided on ICT
infrastructure managed by the EMCDDA;
·       User personal data is collected and stored in system directories
and in log files concerning the following components: ICT systems,
databases and information systems (applications). For guest users, this
includes date, time, client (user) IP address, service name, server IP
address, server port, method, URI stem, protocol status, user agent
(browser), URL. For registered or internal users, additional contact
information is stored  according to the type of their relationship with
the EMCDDA.
·       Personal data of users, for example as recorded in log files, is
accessible to EMCDDA ICT systems, network and security managers,
including: (1) ICT unit staff members dealing with ICT support, and (2)
external service providers, for the purpose of resolving the technical
issues. While performing their tasks, both the EMCDDA and the contractors
are not allowed to take copies of the data to transport outside the EMCDDA
premises. Moreover no such data is communicated to any third parties.
·       In order to protect all EMCDDA data, including the personal data
residing in the EMCDDA ICT infrastructure, a number of technical and
organisational measures have been put in place. These define how to
prevent and react to unauthorised access to equipment and data, or data
loss through system failure. Backup and security procedures are defined
following best practice.
Adherence to best practice, including ICT security, and compliance with
the relevant procedures at EU level, is audited by the European
Commission’s Internal Audit Service.
Please note that in accordance with the EMCDDA regulation (article 1, § 5
of the Regulation (EC) No 1920/2006 of the European Parliament and of the
Council of 12 December 2006, “The Centre shall not collect any data making
it possible to identify individuals or small groups of individuals. It
shall refrain from any transmission of information relating to specific
named cases”.
We really hope these elements provide you with a whole picture on the
requested issues.
Feel free to come back to the EMCDDA, should you have any additional
clarification or request and thank you once again for your interest in the
EMCDDA activities.
 
Yours sincerely,
Vaughan Birbeck
 
 
 

References

Visible links
1. http://www.emcdda.europa.eu/best-practice
2. http://www.emcdda.europa.eu/countries
3. http://www.emcdda.europa.eu/drug-profiles
4. http://www.emcdda.europa.eu/eldd
5. http://www.emcdda.europa.eu/stats12
6. http://www.emcdda.europa.eu/html.cfm/ind...
7. http://www.emcdda.europa.eu/